Surgery is central in primary congenital glaucoma, but success is not guaranteed by the first operation and care does not end in the operating theatre. Microcatheter trabeculotomy is promising, not proven superior for every childhood glaucoma.
Terminology and draft status
Terminology review is not complete. Selected actual WHO UMD queries and their limits are recorded in terminology.md; they do not approve the whole translation.
01Recognise the disease and the uncertainty around its frequency
Primary congenital glaucoma (PCG) is rare. The original lecture cites an incidence of 1:10,000 to 1:30,000; the 2025 European Glaucoma Society (EGS) guideline gives approximately 1:12,000 to 1:18,000 in white European populations. Both are estimates shaped by the population, case definition and completeness of case finding, so neither is a universal rate. 1 2
The lecture suggests that the true incidence is lower because some children are missed. Incomplete diagnosis can indeed make a disease appear rarer, but missed or misclassified cases cannot by themselves prove a lower true incidence: better ascertainment can also raise the recorded rate. Report the estimate with its setting and uncertainty rather than presenting it as a fixed biological constant. 1 2
Childhood glaucoma includes PCG, juvenile open-angle glaucoma (JOAG), glaucoma associated with non-acquired ocular or systemic conditions, acquired causes and glaucoma following cataract surgery (GFCS). Anatomy, presentation and treatment differ. Rarity and heterogeneous small series limit comparisons; PCG surgical conclusions cannot be transferred automatically to all childhood glaucoma. 1 2 3
02Read the angle as a developmental anomaly
The older concept of a Barkan membrane as a discrete sheet blocking the angle is historical. Gonioscopy in many children shows an apparent membrane produced by the abnormal angle anatomy, not a membrane that has been proven to obstruct every affected eye. The term can be retained when explaining the history of the disease, but it should not be taught as the universal mechanism. 1 2
PCG involves developmental abnormality of the trabecular meshwork and outflow pathway. A high iris insertion and poorly differentiated angle structures may be seen. The original depicts fibrous strands pulling the iris root upward and obscuring Schlemm canal; retain this as a proposed teaching mechanism, not a proven uniform causal sequence in every eye or every secondary glaucoma. 1 2
For clinical work, describe what the angle actually shows and whether the cornea is clear enough to see it. These findings help choose between goniotomy and trabeculotomy and warn that Schlemm canal may be absent, hypoplastic or hard to locate, especially in secondary glaucoma. The surgical plan should follow the individual anatomy rather than an assumed diagnosis alone. 1 2 3
03Plan surgery and lifelong care together
In PCG, primary surgery is the main treatment for nearly all eyes. Pressure-lowering drops can bridge the child to surgery or serve as adjuncts afterwards, but they do not replace definitive angle surgery. This is not identical for every childhood glaucoma: in JOAG and some secondary glaucomas, medical treatment may have a larger initial role. The guideline's PCG pathway should not be applied without checking the diagnosis and anatomy. 1 2
The first operation deserves careful planning: confirm the diagnosis, assess the angle and corneal clarity, treat active infection or other systemic problems, and choose a procedure that the surgical team can perform reproducibly. The original statement that the first operation 'must succeed' is too deterministic. A failed first operation is a serious event that changes the plan, but it is not proof that the child will have a poor outcome, and it should not be framed as blame. Repeat angle surgery, trabeculectomy or a glaucoma drainage device may still control pressure. 1 2 3
Good care combines preoperative counselling, examination under anaesthesia (EUA), amblyopia prevention and lifelong review (Table 1). The EUA documents intraocular pressure (IOP), corneal diameter, axial length, gonioscopy and fundoscopy; these measures also provide the baseline for follow-up. The original schedule of every three months in the first year and at least every six months afterwards is a teaching interval, not a fixed universal rule. Review more often when pressure is uncontrolled, soon after surgery, or when amblyopia risk is high. 1 2 3
Parents and carers should understand from the beginning that treatment continues after the operation and into adult life. Appointments, refraction and glasses, patching or other amblyopia treatment, and educational or low-vision support may all be needed. A planned transition to adult glaucoma care is part of the treatment, not an optional extra. 1 2
| Component | Implementation and limits |
|---|---|
| Preoperative counselling | Detailed discussions with parents or carers to reduce fear and set realistic expectations; explain that care is lifelong and that further surgery or amblyopia treatment may be needed. |
| Examination under anaesthesia | EUA including IOP, corneal diameter, axial length, gonioscopy and fundoscopy; record which measurements are reliable and repeat when the clinical picture changes. |
| Amblyopia prophylaxis | Postoperative amblyopia prevention with community ophthalmologists and orthoptists; the original interval of every 3 months in the first year and at least every 6 months afterwards is a teaching schedule, individualized and closer when pressure is uncontrolled, after surgery or with high amblyopia risk. |
| Lifelong review | Care does not end with surgery; continue pressure, vision, refraction and optic-nerve review into adulthood, with a planned transition to adult glaucoma care. |
04Choose and describe the angle operation precisely
Trabeculotomy is the established angle operation for PCG; goniotomy is an alternative when the cornea is clear enough to see the angle. The choice depends on angle anatomy, corneal clarity, the surgeon's experience and the individual eye, not on one universal ranking. The trend is toward a circumferential 360° opening of Schlemm canal when the canal can be cannulated. 1 2 3
The original contrasts an illuminated microcatheter with a conventional rigid probe. A conventional probe generally opens a sector—in PIRATE, 90–120°—while the microcatheter attempts a circumferential 360° opening. The lecture also contrasts childhood canaloplasty without a retained tension suture with the adult technique; distinguish canal probing, canaloplasty and opening the trabecular wall rather than treating all procedures as interchangeable. 1 2 5
If angle surgery fails or is not feasible, options include repeat angle surgery, trabeculectomy and glaucoma drainage devices. The choice depends on the angle and cornea, previous surgery, lens status, the fellow eye and the family's ability to attend follow-up. The EGS guideline supports further filtration or drainage-device surgery after failed primary angle surgery; a failed first procedure does not make the eye untreatable. 2 3
05Appraise the comparative evidence without overranking
Rojas and Bohnsack reported 85 operated eyes of 60 patients aged ≤18; analysis used only the first operated eye in bilateral cases. Catheter passage was attempted in 52 of the 60 analysed eyes and complete 360° passage occurred in 21/52 (40%). The lecture’s 42% is the historical claim being corrected. Complete canal passage is an anatomical endpoint, distinct from pressure success and from another series’ 42% IOP endpoint. 1 3
Canalization varied by diagnosis: 22% in PCG, 69% in JOAG, 36% in glaucoma following cataract surgery (GFCS) and 29% in other types. These are passage rates, not surgical success. In the same series, success was defined as IOP 5–20 mmHg without new glaucoma surgery; five-year success survival was 75% (95% CI 57–86). Eyes with a full 360° opening had 100% survival, the 270–360° group 69% (95% CI 16–93), and the <180° conventional group 48% (95% CI 29–64). Subgroups were small and selected by anatomy, and the confidence intervals are wide. The data show an association, not a proven causal dose–response between degrees opened and success. 1 3
The 2020 Cochrane review included 16 trials with 587 eyes of 446 children younger than 5 years. For microcatheter versus conventional surgery, two trials with 95 children provided moderate-certainty evidence: at 12 months the mean IOP difference was −1.77 mmHg (95% CI −2.92 to −0.63), and success was more frequent with the microcatheter (risk ratio 1.54, 95% CI 1.20–1.97; 99 eyes). Hyphema occurred in 40% versus 17% (risk ratio 2.25, 95% CI 1.25–4.04). Certainty was limited by small samples. Most other procedure comparisons were of very low certainty, so the review does not establish a universal ranking for every childhood glaucoma type. 1 4
The original also cites a 2020 five-study meta-analysis of 315 eyes and the two-year Cairo randomised comparison by El-Sayed and Gawdat. These address microcatheter versus conventional trabeculotomy, but limited study size, varying success definitions and selected populations prevent a universal ranking. A two-year comparison cannot be replaced by results from a different one-year trial. 1 7 8
06Separate the PIRATE protocol from its current status
PIRATE (Probe versus micRocatheter-Assisted circumferential Trabeculotomy) is a multicentre, prospective, randomised trial in children with bilateral primary or secondary glaucoma. The 2025 protocol plans 76 children and 152 eyes, with an age limit of 12 years in that protocol. Each child receives a 360° microcatheter-assisted trabeculotomy (MCAT) in one eye and a metal-probe trabeculotomy of 90–120° in the other; this is not a comparison of 360° with 360°. The primary outcome is complete success with IOP below 18 mmHg without medication or revision, and successful microcatheter probing beyond 120° is also required. Follow-up is 24 months, with observer and patient masking. The analysis is paired by child and stratified by centre using McNemar-type methods, so 152 eyes are not 152 independent patients. 1 5
The public register DRKS 00034139 was updated on 12 October 2026 and records recruiting ongoing, an actual start on 23 May 2024 and planned completion on 1 December 2029. The target is 76 children and no results are posted. The register allows ages up to 17 years and adds an explicit ≤17 criterion, while the trial's own scientific summary and the 2025 protocol state ≤12 years. This discrepancy is documented and left unresolved here; it is not silently reconciled or presented as a verified amendment. 5 6
The current register lists Mainz, Cologne, Leuven, Magdeburg and Munich, with funding from the German Research Foundation (DFG). The lecture's statement that the study was in the second year of five is a dated snapshot, not current status. The original account of parent and child information material, ethics review and the appeal for referrals is retained as historical context. It should not be turned into a current clinical referral instruction without verifying the trial's present eligibility and sites. 1 5 6
| Feature | Details and status |
|---|---|
| Objective | Prospective randomised comparison of 360° microcatheter-assisted trabeculotomy (MCAT) with conventional metal-probe trabeculotomy of 90–120° in children with bilateral primary or secondary glaucoma. |
| Design | Multicentre, prospective, randomised, paired-eye trial; one eye per technique; observer and patient masking; 24-month follow-up; paired analysis by child stratified by centre (McNemar), not 152 independent patients. |
| Planned cohort | Planned 76 children and 152 eyes; 2025 protocol age ≤12 years; register eligibility up to 17 years with an additional ≤17 criterion — discrepancy unresolved here. |
| Follow-up | 24 months. |
| Centres | Mainz (lead), Cologne, Leuven and Magdeburg; Munich is also listed in the current register. |
| Funding | German Research Foundation (DFG). |
| Current status | Recruiting; actual start 23 May 2024; planned completion 1 December 2029; target 76 children; no results posted (register updated 12 October 2026). The original 'year 2 of 5' is dated and not current status. |
07Keep the long view and the research horizon
The practical summary is therefore: PCG is rare; primary surgery is central for nearly all PCG; goniotomy or trabeculotomy is chosen by angle anatomy and corneal clarity; circumferential microcatheter surgery is promising but not proven superior for every type; failed surgery has further options; and lifelong IOP, axial length, orthoptic and refractive follow-up with amblyopia care is part of treatment. 1 2 3 4
The lecture presents genetic and vector approaches to the trabecular meshwork as preclinical research that might eventually support surgery. The selected sources here establish no approved alternative or clinical benefit for this indication. Do not infer availability or replace established care from this research prospect alone. 1
Document the diagnosis, angle findings, operation and follow-up plan so that another clinician can continue care. The evidence base is small and partly observational; local paediatric glaucoma expertise and individual anatomy should fill the gaps rather than a single universal rule. 1 2
What are the main learning points?
PCG is rare and primary surgery is central for nearly all cases; goniotomy or trabeculotomy is chosen by anatomy and corneal clarity. Circumferential microcatheter surgery is promising but not proven superior for every type, and a failed first operation does not remove later options. Lifelong pressure, vision, refractive and amblyopia follow-up is part of treatment.
Which findings need urgent assessment?
Rapid visual deterioration, severe pain, marked inflammation, rising pressure or suspected infectious or neurological causes need urgent assessment.
References and access status
- 1Immutable original export; childhood glaucoma therapy lecture
Complete raw export read; no independent video, recording, biography or image verification.
- 2European Glaucoma Society guidelines, 6 th edition (2025)
Selected cached childhood-glaucoma text printed pp 117–120 reread 13 November 2026; not the entire book, figures or image appraisal. DOI 10.1136/bjophthalmol-2025-egsguidelines.
- 3Rojas & Bohnsack: circumferential trabeculotomy outcomes in paediatric glaucoma (AJO 2020)
Complete NCBI abstract read 13 November 2026; retrospective 85 eyes/60 children, first operated eye only for bilateral cases. Full report unread.
- 4Cochrane review: surgical interventions for primary congenital glaucoma (2020)
Complete abstract read 13 November 2026; 16 trials, 587 eyes, 446 children under 5. Full review and trial tables unread.
- 5PIRATE trial protocol: probe versus microcatheter-assisted circumferential trabeculotomy (2025)
Complete abstract read 13 November 2026; published protocol, not results. Full PMC/protocol appraisal not claimed.
- 6DRKS 00034139: PIRATE trial registration
Complete register read 13 November 2026 (updated 12 October 2026); recruiting, no results. Eligibility discrepancy documented, no verified amendment claimed.
- 7Five-study meta-analysis of microcatheter versus conventional trabeculotomy (2020)
Indexed abstract only located 13 November 2026; not a full appraisal.
- 8El-Sayed & Gawdat: two-year randomised trial of microcatheter-assisted trabeculotomy, Cairo (Acta Ophthalmol 2017)
Selected publisher-indexed design and reoperation information read 13 November 2026; direct full text returned 403. No effect estimate invented.
For patients
Childhood glaucoma is rare. Most children with primary congenital glaucoma need an operation to improve drainage; eye drops may be used before surgery or alongside it. Not every childhood glaucoma behaves the same way.
The first operation is planned carefully, but further surgery or medication may still be needed. Lifelong check-ups, glasses and amblyopia treatment are part of care, not extras.
This is educational information, not individual medical advice. Rapid visual deterioration, severe pain, marked inflammation, rising pressure or suspected infection or neurological disease needs urgent assessment.
Rapid visual deterioration, severe pain, marked inflammation, rising pressure or suspected infectious or neurological causes need urgent assessment.